Mkts

Arcutis Biotherapeutics, Inc.

NASDAQ: ARQT
$27.17-0.44 (-1.59%)
As of Nov 19, 4:00 PM ET

Key statistics

Day range
26.9828.17
52-week range
19.3034.80
Today
Open27.74
Previous close27.17
Volume17.1K
Valuation
Market cap3.44B
P/E ratio114.91×
EPS (TTM)0.22
Income & risk
Dividend / yield—
Beta1.62
Avg volume2.30M
Discussion

ARQT News

Stories mentioning ARQT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue105,398129,50399,21981,50465,84671,36044,75530,858
Cost of Goods Sold9,78411,6888,6857,4928,8306,9055,5033,464
Gross Profit95,614117,81590,53474,01257,01664,45539,25227,394
Operating Expenses
Research & Development30,62720,45119,60419,45317,54314,48019,50119,298
Sales General & Admin74,07678,97762,40469,17064,00257,60758,81758,173
Total Operating Expenses
Operating Income (Loss)(9,089)18,3878,526(14,611)(24,529)(7,632)(39,066)(50,077)
Interest Income
Interest Expense
Other Expense(20.00)(3,881)2,0352,096193.00(13,408)4,1825,229
Pretax Income
Tax Provision93.00470.0080.00342.00279.00323.000.000.00
Net Income (Loss)(11,295)17,3957,410(15,886)(25,060)(10,788)(41,537)(52,332)
Earnings Per Share (Basic)(0.09)0.140.06(0.13)(0.20)(0.09)(0.33)(0.42)
Earnings Per Share (Diluted)(0.09)0.140.06(0.13)(0.20)(0.09)(0.33)(0.42)
Weighted Average Shares Outstanding (Basic)129.00127,234127,623126,997126.00120,958124,302123,481
Weighted Average Shares Outstanding (Diluted)129.00127,234132,885126,997126.00120,958124,302123,481

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ARQT

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a stock listed on the Nasdaq Stock Market under the ticker symbol ARQT. It last traded at $27.17 (Nov 19, 2026, 4:00 PM ET), down 1.6% on the day. That gives Arcutis Biotherapeutics a market capitalisation of $3.4B and a price-to-earnings ratio of 114.9.

Over the past 52 weeks ARQT has traded between $19.30 and $34.80.

Revenue for the quarter ended Mar 31, 2026 was $105.4M; a net loss of $11.3M. Revenue was up 60.1% from $65.8M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$105.4M-$11.3M-10.7%
Dec 31, 2025$129.5M$17.4M13.4%
Sep 30, 2025$99.2M$7.4M7.5%
Jun 30, 2025$81.5M-$15.9M-19.5%

From Arcutis Biotherapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…